ARTICLE | Management Tracks
Luo joins Everest as CEO
Plus Hitchcock named CSO at Takeda, and updates from Viracta, Agios, Aktis and more
September 20, 2022 12:13 AM UTC
Everest Medicines Ltd. (HKEX:1952) named Rogers Luo as CEO and executive director. Luo was president and general manager of Greater China at Brii Biosciences Ltd. (HKEX:2137), and CEO of TSB Therapeutics. Everest is developing therapies for oncology, autoimmune, cardio-renal and infectious diseases.
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) named Head of Research Steve Hitchcock as the company’s new CSO. ...